Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Statistics

Total Valuation

GLUE has a market cap or net worth of $532.04 million. The enterprise value is $315.12 million.

Market Cap	532.04M
Enterprise Value	315.12M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

GLUE has 61.44 million shares outstanding. The number of shares has increased by 36.96% in one year.

Current Share Class	61.44M
Shares Outstanding	61.44M
Shares Change (YoY)	+36.96%
Shares Change (QoQ)	+15.13%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	51.22%
Float	36.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.75
Forward PS	54.58
PB Ratio	2.50
P/TBV Ratio	2.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	21.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.21.

Current Ratio	6.03
Quick Ratio	5.83
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.23% and return on invested capital (ROIC) is -33.58%.

Return on Equity (ROE)	-61.23%
Return on Assets (ROA)	-28.43%
Return on Capital (ROIC)	-33.58%
Revenue Per Employee	$112,594
Profits Per Employee	-$897,662
Employee Count	133
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, GLUE has paid $384,000 in taxes.

Income Tax	384,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +149.55% in the last 52 weeks. The beta is 1.30, so GLUE's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+149.55%
50-Day Moving Average	6.66
200-Day Moving Average	5.61
Relative Strength Index (RSI)	54.95
Average Volume (20 Days)	6,087,256

Short Selling Information

The latest short interest is 7.84 million, so 12.76% of the outstanding shares have been sold short.

Short Interest	7.84M
Short Previous Month	5.23M
Short % of Shares Out	12.76%
Short % of Float	21.21%
Short Ratio (days to cover)	1.65

Income Statement

In the last 12 months, GLUE had revenue of $14.98 million and -$119.39 million in losses. Loss per share was -$1.77.

Revenue	14.98M
Gross Profit	16.78M
Operating Income	-128.98M
Pretax Income	-129.93M
Net Income	-119.39M
EBITDA	-121.07M
EBIT	-128.98M
Loss Per Share	-$1.77

Balance Sheet

The company has $242.19 million in cash and $43.70 million in debt, giving a net cash position of $198.49 million or $3.23 per share.

Cash & Cash Equivalents	242.19M
Total Debt	43.70M
Net Cash	198.49M
Net Cash Per Share	$3.23
Equity (Book Value)	205.46M
Book Value Per Share	3.35
Working Capital	209.57M

Cash Flow

In the last 12 months, operating cash flow was -$57.29 million and capital expenditures -$5.49 million, giving a free cash flow of -$62.79 million.

Operating Cash Flow	-57.29M
Capital Expenditures	-5.49M
Free Cash Flow	-62.79M
FCF Per Share	-$1.02

Margins

Gross Margin	112.03%
Operating Margin	-861.30%
Pretax Margin	-794.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,176.56%

Dividends & Yields

GLUE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.96%
Shareholder Yield	-36.96%
Earnings Yield	-22.76%
FCF Yield	-11.97%

Analyst Forecast

The average price target for GLUE is $14.67, which is 69.40% higher than the current price. The consensus rating is "Buy".

Price Target	$14.67
Price Target Difference	69.40%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GLUE has an Altman Z-Score of -1.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.04
Piotroski F-Score	1